141 related articles for article (PubMed ID: 21356574)
61. Mevalonate Pathway Antagonist Suppresses Formation of Serous Tubal Intraepithelial Carcinoma and Ovarian Carcinoma in Mouse Models.
Kobayashi Y; Kashima H; Wu RC; Jung JG; Kuan JC; Gu J; Xuan J; Sokoll L; Visvanathan K; Shih IeM; Wang TL
Clin Cancer Res; 2015 Oct; 21(20):4652-62. PubMed ID: 26109099
[TBL] [Abstract][Full Text] [Related]
62. Metformin as an adjuvant drug against pediatric sarcomas: hypoxia limits therapeutic effects of the drug.
Garofalo C; Capristo M; Manara MC; Mancarella C; Landuzzi L; Belfiore A; Lollini PL; Picci P; Scotlandi K
PLoS One; 2013; 8(12):e83832. PubMed ID: 24391834
[TBL] [Abstract][Full Text] [Related]
63. Quercetin Augments Cisplatin-Induced Apoptosis, DNA Damage Response, and MiR-22 Expression While It Prevents DNA Repair in Osteosarcoma Cells.
Malakoti F; Majidinia M; Ahmadi Y; Yousefi B; Shanebandi D
Drug Res (Stuttg); 2022 Sep; 72(7):378-384. PubMed ID: 35724673
[TBL] [Abstract][Full Text] [Related]
64. Acute apoptosis by cisplatin requires induction of reactive oxygen species but is not associated with damage to nuclear DNA.
Berndtsson M; Hägg M; Panaretakis T; Havelka AM; Shoshan MC; Linder S
Int J Cancer; 2007 Jan; 120(1):175-80. PubMed ID: 17044026
[TBL] [Abstract][Full Text] [Related]
65. Modeling chemotherapy-induced stress to identify rational combination therapies in the DNA damage response pathway.
Alkan O; Schoeberl B; Shah M; Koshkaryev A; Heinemann T; Drummond DC; Yaffe MB; Raue A
Sci Signal; 2018 Jul; 11(540):. PubMed ID: 30042127
[TBL] [Abstract][Full Text] [Related]
66. Chromatin-associated proteins HMGB1/2 and PDIA3 trigger cellular response to chemotherapy-induced DNA damage.
Krynetskaia NF; Phadke MS; Jadhav SH; Krynetskiy EY
Mol Cancer Ther; 2009 Apr; 8(4):864-72. PubMed ID: 19372559
[TBL] [Abstract][Full Text] [Related]
67. Comparative study of p53 expression in human carcinoma cell lines A549 and MCF7 under anticancer drug treatment.
Filyak OS; Stoika RS
Ukr Biokhim Zh (1999); 2005; 77(2):136-40. PubMed ID: 16335246
[TBL] [Abstract][Full Text] [Related]
68. Hyperthermia Synergizes with Chemotherapy by Inhibiting PARP1-Dependent DNA Replication Arrest.
Schaaf L; Schwab M; Ulmer C; Heine S; Mürdter TE; Schmid JO; Sauer G; Aulitzky WE; van der Kuip H
Cancer Res; 2016 May; 76(10):2868-75. PubMed ID: 27013194
[TBL] [Abstract][Full Text] [Related]
69. Apoptosis induced by chamaejasmine in human osteosarcoma cells through p53 pathway.
Yang D; Wang P; Ren X
Tumour Biol; 2015 Jul; 36(7):5433-9. PubMed ID: 25677904
[TBL] [Abstract][Full Text] [Related]
70. Synergistic cytotoxic effects of inorganic phosphate and chemotherapeutic drugs on human osteosarcoma cells.
Spina A; Sorvillo L; Chiosi E; Esposito A; Di Maiolo F; Sapio L; Caraglia M; Naviglio S
Oncol Rep; 2013 May; 29(5):1689-96. PubMed ID: 23446517
[TBL] [Abstract][Full Text] [Related]
71. Inhibition of the mevalonate pathway affects epigenetic regulation in cancer cells.
Karlic H; Thaler R; Gerner C; Grunt T; Proestling K; Haider F; Varga F
Cancer Genet; 2015 May; 208(5):241-52. PubMed ID: 25978957
[TBL] [Abstract][Full Text] [Related]
72. The enhancing effect of a laser photochemotherapy with cisplatin or zolendronic acid in primary human osteoblasts and osteosarcoma cells in vitro.
Heymann PG; Ziebart T; Kämmerer PW; Mandic R; Saydali A; Braun A; Neff A; Draenert GF
J Oral Pathol Med; 2016 Nov; 45(10):803-809. PubMed ID: 27122094
[TBL] [Abstract][Full Text] [Related]
73. Induction of DNA damage and apoptosis in human leukemia cells by efavirenz.
Brüning A; Jückstock J; Kost B; Tsikouras P; Weissenbacher T; Mahner S; Mylonas I
Oncol Rep; 2017 Jan; 37(1):617-621. PubMed ID: 27878300
[TBL] [Abstract][Full Text] [Related]
74. Anti-cancer activity of trans-chalcone in osteosarcoma: Involvement of Sp1 and p53.
Silva G; Marins M; Fachin AL; Lee SH; Baek SJ
Mol Carcinog; 2016 Oct; 55(10):1438-48. PubMed ID: 26294168
[TBL] [Abstract][Full Text] [Related]
75. Targeting the mevalonate pathway for improved anticancer therapy.
Fritz G
Curr Cancer Drug Targets; 2009 Aug; 9(5):626-38. PubMed ID: 19508172
[TBL] [Abstract][Full Text] [Related]
76. Metformin and caffeic acid regulate metabolic reprogramming in human cervical carcinoma SiHa/HTB-35 cells and augment anticancer activity of Cisplatin via cell cycle regulation.
Tyszka-Czochara M; Bukowska-Strakova K; Majka M
Food Chem Toxicol; 2017 Aug; 106(Pt A):260-272. PubMed ID: 28576465
[TBL] [Abstract][Full Text] [Related]
77. Anti-cancer characteristics of mevinolin against three different solid tumor cell lines was not solely p53-dependent.
Mahmoud AM; Al-Abd AM; Lightfoot DA; El-Shemy HA
J Enzyme Inhib Med Chem; 2012 Oct; 27(5):673-9. PubMed ID: 21883038
[TBL] [Abstract][Full Text] [Related]
78. Targeting the DNA damage response (DDR) by natural compounds.
van Stuijvenberg J; Proksch P; Fritz G
Bioorg Med Chem; 2020 Feb; 28(4):115279. PubMed ID: 31980363
[TBL] [Abstract][Full Text] [Related]
79. Cell cycle-specific effects of lovastatin.
Jakóbisiak M; Bruno S; Skierski JS; Darzynkiewicz Z
Proc Natl Acad Sci U S A; 1991 May; 88(9):3628-32. PubMed ID: 1673788
[TBL] [Abstract][Full Text] [Related]
80. Integral membrane protease fibroblast activation protein sensitizes fibrosarcoma to chemotherapy and alters cell death mechanisms.
Baird SK; Rigopoulos A; Cao D; Allan L; Renner C; Scott FE; Scott AM
Apoptosis; 2015 Nov; 20(11):1483-98. PubMed ID: 26342814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
